Patient Pathfinder: Clinical Trials
Clinical Trials for Transthyretin Amyloid Cardiomyopathy
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 32 active Transthyretin Amyloid Cardiomyopathy trials
Exercise Training in Transthyretin Cardiac Amyloidosis
Study Type: Interventional
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
Study Type: Interventional Early Phase 1
A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis
Study Type: Interventional Phase 2
CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Study Type: Interventional Phase 3
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Study Type: Observational
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Study Type: Interventional Phase 3
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Study Type: Interventional Phase 3
There are 32 active Transthyretin Amyloid Cardiomyopathy trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now